169 related articles for article (PubMed ID: 26568317)
1. Gastro-esophageal reflux and antisecretory drugs use among patients with chronic autoimmune atrophic gastritis: a study with pH-impedance monitoring.
Tenca A; Massironi S; Pugliese D; Consonni D; Mauro A; Cavalcoli F; Franchina M; Spampatti M; Conte D; Penagini R
Neurogastroenterol Motil; 2016 Feb; 28(2):274-80. PubMed ID: 26568317
[TBL] [Abstract][Full Text] [Related]
2. Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease.
Tenca A; de Bortoli N; Mauro A; Frazzoni M; Savarino E; Massironi S; Russo S; Bertani L; Marchi S; Penagini R
Dig Liver Dis; 2017 Sep; 49(9):978-983. PubMed ID: 28487082
[TBL] [Abstract][Full Text] [Related]
3. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
Mainie I; Tutuian R; Shay S; Vela M; Zhang X; Sifrim D; Castell DO
Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
5. Direct measurement of gastroesophageal reflux episodes in patients with squamous cell carcinoma by 24-h pH-impedance monitoring.
Uno K; Iijima K; Hatta W; Koike T; Abe Y; Asano N; Kusaka G; Shimosegawa T
Am J Gastroenterol; 2011 Nov; 106(11):1923-9. PubMed ID: 21931379
[TBL] [Abstract][Full Text] [Related]
6. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
[TBL] [Abstract][Full Text] [Related]
7. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.
Ribolsi M; Savarino E; De Bortoli N; Balestrieri P; Furnari M; Martinucci I; Casale M; Greco F; Salvinelli F; Savarino V; Marchi S; Cicala M
Aliment Pharmacol Ther; 2014 Oct; 40(8):966-73. PubMed ID: 25109844
[TBL] [Abstract][Full Text] [Related]
8. Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux.
Roman S; Keefer L; Imam H; Korrapati P; Mogni B; Eident K; Friesen L; Kahrilas PJ; Martinovich Z; Pandolfino JE
Neurogastroenterol Motil; 2015 Nov; 27(11):1667-74. PubMed ID: 26337396
[TBL] [Abstract][Full Text] [Related]
9. 24-hour pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study.
Desjardin M; Luc G; Collet D; Zerbib F
Neurogastroenterol Motil; 2016 Jan; 28(1):146-52. PubMed ID: 26526815
[TBL] [Abstract][Full Text] [Related]
10. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
Weigt J; Kandulski A; Büsch F; Malfertheiner P
Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring.
Patel A; Sayuk GS; Gyawali CP
Neurogastroenterol Motil; 2016 Sep; 28(9):1382-90. PubMed ID: 27061427
[TBL] [Abstract][Full Text] [Related]
12. A study with pharyngeal and esophageal 24-hour pH-impedance monitoring in patients with laryngopharyngeal symptoms refractory to proton pump inhibitors.
Dulery C; Lechot A; Roman S; Bastier PL; Stoll D; de Gabory L; Zerbib F
Neurogastroenterol Motil; 2017 Jan; 29(1):. PubMed ID: 27424517
[TBL] [Abstract][Full Text] [Related]
13. Can acid (pH) refluxes predict multichannel intraluminal impedance refluxes? A correlation study.
Misra S
J Gastroenterol Hepatol; 2010 Apr; 25(4):817-22. PubMed ID: 20492340
[TBL] [Abstract][Full Text] [Related]
14. Cough and gastroesophageal reflux: from the gastroenterologist end.
Pauwels A; Blondeau K; Dupont L; Sifrim D
Pulm Pharmacol Ther; 2009 Apr; 22(2):135-8. PubMed ID: 19063984
[TBL] [Abstract][Full Text] [Related]
15. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
16. High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease--a prospective pH-metry/impedance-controlled study.
Bajbouj M; Becker V; Phillip V; Wilhelm D; Schmid RM; Meining A
Digestion; 2009; 80(2):112-8. PubMed ID: 19641320
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
[TBL] [Abstract][Full Text] [Related]
18. Objective Evidence of Gastro-Esophageal Reflux Disease is Rare in Patients with Autoimmune Gastritis.
Pilotto V; Maddalo G; Orlando C; Fassan M; Rugge M; Farinati F; Savarino EV
J Gastrointestin Liver Dis; 2021 Mar; 30(1):30-36. PubMed ID: 33723550
[TBL] [Abstract][Full Text] [Related]
19. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.
Patel A; Sayuk GS; Kushnir VM; Chan WW; Gyawali CP
Neurogastroenterol Motil; 2016 Apr; 28(4):513-21. PubMed ID: 26686239
[TBL] [Abstract][Full Text] [Related]
20. Increasing body weight enhances prevalence and proximal extent of reflux in GERD patients 'on' and 'off' PPI therapy.
Blondeau K; Boecxstaens V; Van Oudenhove L; Farré R; Boeckxstaens G; Tack J
Neurogastroenterol Motil; 2011 Aug; 23(8):724-e327. PubMed ID: 21535319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
